These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16529065)
1. [Current review on the role of transforming growth factor beta (TGF-beta) in some pathological disorders]. Krzemień S; Knapczyk P Wiad Lek; 2005; 58(9-10):536-9. PubMed ID: 16529065 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Roles of transforming growth factor-β in graft-versus-host and graft-versus-tumor effects. Carli C; Giroux M; Delisle JS Biol Blood Marrow Transplant; 2012 Sep; 18(9):1329-40. PubMed ID: 22326303 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation. Seggewiss R; Einsele H Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184 [TBL] [Abstract][Full Text] [Related]
5. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. McCormick LL; Zhang Y; Tootell E; Gilliam AC J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100 [TBL] [Abstract][Full Text] [Related]
6. Autoimmunity following haematopoietic stem-cell transplantation. Daikeler T; Tyndall A Best Pract Res Clin Haematol; 2007 Jun; 20(2):349-60. PubMed ID: 17448966 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta and atherosclerosis in man. Grainger DJ Cardiovasc Res; 2007 May; 74(2):213-22. PubMed ID: 17382916 [TBL] [Abstract][Full Text] [Related]
8. [Transforming growth factor (TGF-beta) and kidney transplantation]. Matl I; Viklický O Cas Lek Cesk; 2002 Sep; 141(19):601-4. PubMed ID: 12501502 [TBL] [Abstract][Full Text] [Related]
9. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105 [TBL] [Abstract][Full Text] [Related]
10. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts. Rintala JM; Savikko J; Rintala SE; von Willebrand E Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624 [TBL] [Abstract][Full Text] [Related]
11. Chronic GVHD as an autoimmune disease. Tyndall A; Dazzi F Best Pract Res Clin Haematol; 2008 Jun; 21(2):281-9. PubMed ID: 18503993 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation. Nachbaur D; Schumacher P; Auberger J; Clausen J; Kircher B Biol Blood Marrow Transplant; 2007 Aug; 13(8):942-7. PubMed ID: 17640598 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of SMAD3 transcripts is not regulated by cis-acting genetic elements but has a gender specificity. Busque L; Belisle C; Provost S; Giroux M; Perreault C Genes Immun; 2009 Mar; 10(2):192-6. PubMed ID: 19129849 [TBL] [Abstract][Full Text] [Related]
17. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation. Foss FM Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113 [TBL] [Abstract][Full Text] [Related]
18. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877 [TBL] [Abstract][Full Text] [Related]
19. The immunopharmacological properties of transforming growth factor beta. Le Y; Yu X; Ruan L; Wang O; Qi D; Zhu J; Lu X; Kong Y; Cai K; Pang S; Shi X; Wang JM Int Immunopharmacol; 2005 Dec; 5(13-14):1771-82. PubMed ID: 16275614 [TBL] [Abstract][Full Text] [Related]
20. The role of transforming growth factor-beta in atherosclerosis. Singh NN; Ramji DP Cytokine Growth Factor Rev; 2006 Dec; 17(6):487-99. PubMed ID: 17056295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]